CAV1 and gastric cancer: For example, researchers found that the circRNA circCCDC9 functions as a tumor suppressor molecule in inhibiting the progression of gastric cancer through the miR-6792-3p/CAV1 axis; this provided a useful biomarker and therapeutic target for patients with gastric cancer [20].